Soft Tissue Sarcoma (STS) Recruiting Phase 3 Trials for Glasdegib (DB11978)

Back to Soft Tissue Sarcoma (STS)

Also known as: Sarcoma, Soft Tissue / Soft Tissue Sarcomas / Soft tissue sarcoma / Sarcoma,Soft Tissue / Malignant neoplasm of soft tissues / Malignant soft tissue neoplasm / Malignant soft tissue neoplasm NOS / Soft tissue cancer / Sarcoma NOS / Sarcoma

Indication	Status	Phase
DBCOND0056871 (Soft Tissue Sarcoma (STS))	Recruiting	3

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT03784014	Molecular Profiling of Advanced Soft-tissue Sarcomas	Health Services Research	Capmatinib (DB11791) Ceritinib (DB09063) Dabrafenib (DB08912) Durvalumab (DB11714) Futibatinib (DB15149) Glasdegib (DB11978) Lapatinib (DB01259) Nilotinib (DB04868) Olaparib (DB09074) Palbociclib (DB09073) Trametinib (DB08911)